• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Chronic Disease

Dupilumab improves symptoms and increases remission rates in eosinophilic esophagitis

byGrace YinandKiera Liblik
January 9, 2023
in Chronic Disease, Gastroenterology
Reading Time: 2 mins read
Extensive lymphadenectomy may not increase patient survival with esophageal cancer
Share on FacebookShare on TwitterShare on LinkedIn

1. Weekly dupilumab resulted in a significantly increased rate of histologic remission as compared to placebo in patients with eosinophilic esophagitis.

2. Weekly dupilumab also resulted in significantly reduced symptoms of dysphagia in comparison to placebo. 

Evidence Rating Level: 1 (Excellent)

Study Rundown: Eosinophilic esophagitis is a chronic immunologic allergic reaction thought to be triggered by exposure to a specific food or environmental allergens. Existing treatments have variable efficacy and do not always address the underlying inflammatory drivers of the condition. Dupilumab is a human monoclonal antibody that works on blocking specific proteins involved in propagating type 2 inflammatory processes involved in eosinophilic esophagitis. This study was a three-part phase 3 trial investigating the efficacy of dupilumab in treating eosinophilic esophagitis in comparison to a placebo. Patients were included who demonstrated poor response to at least eight weeks of treatment on an existing medication of proton-pump inhibitors. Results of the study found that weekly dupilumab was associated with significantly increased rates of histologic remission and decreased dysphagia symptoms as compared to placebo. However, there was no difference in comparison to placebo when dosed every two weeks. This study is limited by generalizability given the overrepresentation of White patients and a relatively short treatment period in comparison to the chronicity of this condition. This study offers insights into the potential utility of dupilumab in providing symptomatic relief and histologic improvement for persons with eosinophilic esophagitis.

Click here to read the study in the NEJM (New England Journal of Medicine)

In-Depth [randomized controlled trial]: This study was a multiple-component, randomized, double-blind, placebo-controlled phase 3 clinical trial investigating the efficacy of dupilumab for treating eosinophilic esophagitis. Persons aged 12 or older with biopsy-confirmed eosinophilic esophagitis after eight weeks of proton-pump inhibitor use and a score of 10 or higher on the Dysphagia Symptoms Questionnaire (DSQ) were included. After applying selection criteria, 81 patients in Part A, 240 patients in Part B, and 37 patients in Part C were randomized in a 1:1 ratio to receive dupilumab or placebo. The primary outcomes of interest were histologic remission at 24 weeks and absolute change in DSQ score. Additional outcomes included eosinophils per high-power field, quality of life, endoscopy findings, use of rescue medications or procedures, and safety. Results of the primary analysis found that significantly more patients achieved histologic remission with dupilumab in comparison to placebo (p<0.001). Dupilumab was also associated with a significant improvement in DSQ scores in comparison to baseline in Part A and B (p<0.05). However, dosing every two weeks with dupilumab did not demonstrate significant improvement as compared to placebo. In terms of safety, the most common adverse event in the dupilumab group was an injection-site reaction. Serious adverse effects leading to discontinuation were reported in five patients receiving dupilumab and two patients receiving a placebo. The reasons for discontinuation were not reported. In summary, this study provided evidence that dupilumab may be superior to placebo in reducing dysphagia symptoms and inducing histologic remission when dosed weekly for patients with eosinophilic esophagitis.

RELATED REPORTS

Male sex is associated with higher mortality among patients with hepatocellular carcinoma

High maternal egg-peanut intake not associated with reduced infant allergy

Image: PD

©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: allergyAllergy and Clinical Immunologychronic diseasedupilumabDysphagiaeosinophilic esophagitisGastroenterology
Previous Post

Perfluorohexyloctane drops significantly improve dry eye due to Meibomian gland dysfunction

Next Post

DART improves treatment decision-making for patients with chronic kidney disease

RelatedReports

A liver illustration with spilled sugar cubes and two drink cups, highlighting the link between sugary drinks and liver health.
Chronic Disease

Male sex is associated with higher mortality among patients with hepatocellular carcinoma

October 7, 2026
A young boy stands beside various processed foods, while a taller teenager stands further along a winding path, symbolizing growth influenced by nutrition.
Chronic Disease

High maternal egg-peanut intake not associated with reduced infant allergy

September 22, 2026
Fatty liver disease may independently predict high-risk coronary disease
Cardiology

Weight loss is associated with improved vascular function in patients with metabolic dysfunction-associated steatotic liver disease

August 21, 2026
Quick Take: Diagnostic Yield of One-Time Colonoscopy vs One-Time Flexible Sigmoidoscopy vs Multiple Rounds of Mailed Fecal Immunohistochemical Tests in Colorectal Cancer Screening
Chronic Disease

Male sex and hispanic ethnicity are associated with increased risk of early-onset colorectal cancer

June 29, 2026
Next Post

DART improves treatment decision-making for patients with chronic kidney disease

Mindfulness-based therapy associated with improvement in quality of life for PTSD patients

Intensive outpatient prolonged exposure effective for combat related posttraumatic stress disorder

Video gaming and youth mental health collage: a teen with headphones around his neck, a game controller and a crescent moon

Religiosity may be protective against internet addiction

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Few patients had ED lumbar CT or MRI within 30 days after low-acuity back-pain radiography at urgent care centers
  • A 34-circular RNA blood signature predicted Alzheimer’s disease progression and improved prediction when combined with pTau217
  • Inhaled corticosteroids do not improve outcomes in sickle cell disease patients without asthma
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ new physician-written study summaries monthly, 12,000+ searchable
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓FDA drug approvals + clinical calculators

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.